Literature DB >> 23402550

Not all non-rheumatoid patients are satisfied with thumb metacarpophalangeal joint arthrodesis.

István Z Rigó1, Magne Røkkum.   

Abstract

Arthrodesis of the thumb metacarpophalangeal (MP) joint exhibits good results in rheumatoid patients but is controversial in post-traumatic conditions. This study evaluated the subjective outcome after thumb MP joint arthrodesis in chronic injuries and non-rheumatoid degenerative disorders. Forty-six patients were evaluated retrospectively with a mean follow-up of 4.1 years (range 1.5-6.5). Both the Quick DASH score (mean 18.6; range 0-72.7) and Visual Analogue Scales (satisfaction, pain, stiffness, and impairment of ADL; mean 3.2, 3.0, 3.0, and 2.5; range 0-9.6, 0-9.1, 0-9.8, and 0-9.6, respectively) showed wide variations. Twelve patients regretted the operation and 37 experienced difficulties with one or more specific activities. Multiple regression analyses indicated that elderly patients with painless instability are the best candidates for thumb MP joint arthrodesis. In young patients with excessively painful thumb MP joints and involvement in Workers' Compensation Board claims, but without advanced degenerative changes, this study recommends avoiding arthrodesis and considering alternative treatment modalities. The importance of adequate preoperative information about the realistic expectations after arthrodesis of the thumb MP joint is emphasised.

Entities:  

Mesh:

Year:  2013        PMID: 23402550     DOI: 10.3109/2000656X.2012.742020

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  2 in total

1.  Long-term Outcomes of Silastic Arthroplasty of the Thumb Metacarpophalangeal Joint.

Authors:  Charles A Cefalu; Philip E Blazar; Barry P Simmons; Brandon E Earp
Journal:  Hand (N Y)       Date:  2019-10-03

2.  Metacarpophalangeal Joint Arthrodesis of the Thumb - Minimum of Eight Months Follow-up.

Authors:  Rasmus Wejnold Jørgensen; Stig Brorson; Claus Hjorth Jensen
Journal:  Open Orthop J       Date:  2016-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.